[Autologous peripheral blood stem cell transplantation combined with bortezomib and dexamethasone for the treatment of light chain proximal tubulopathy: a case report]

Zhonghua Xue Ye Xue Za Zhi. 2019 Aug 14;40(8):703. doi: 10.3760/cma.j.issn.0253-2727.2019.08.019.

[Article in Chinese]

Authors

M N Li¹, L Zhao², X H Li², H A Zhou², X H Huang², Z H Liu¹, Z Cheng²

Affiliations

¹ Department of Nephrology, Jinling Hospital, Nanjing Medical University, Nanjing 210002, China.
² National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing 210002, China.

PMID: 31495145
PMCID: PMC7342878
DOI: 10.3760/cma.j.issn.0253-2727.2019.08.019

No abstract available

Publication types

Case Reports

MeSH terms

Antineoplastic Combined Chemotherapy Protocols
Bortezomib
Dexamethasone
Humans
Multiple Myeloma*
Peripheral Blood Stem Cell Transplantation*
Stem Cell Transplantation
Transplantation, Autologous

Substances

Bortezomib
Dexamethasone